(Q34762112)

4 August 2017

1 reference

title

Strategies for designing vaccines eliciting Th1 responses in humans (English)

1 reference

4 August 2017

Moingeon P

1

1 reference

4 August 2017

publication date

1 September 2002

1 reference

4 August 2017

published in

Journal of Biotechnology

1 reference

4 August 2017

volume

98

1 reference

4 August 2017

issue

2-3

1 reference

4 August 2017

page(s)

189-198

1 reference

Functional diversity of helper T lymphocytes

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Therapeutic strategies for allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Recombinant viruses as a tool for therapeutic vaccination against human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Type 1 and type 2: a fundamental dichotomy for all T-cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Diversity of T cell repertoire shaped by a single peptide ligand is critically affected by its amino acid residue at a T cell receptor contact.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Transcutaneous immunization: T cell responses and boosting of existing immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Antigen-specific therapy for autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

A theoretical approach towards the identification of cleavage-determining amino acid motifs of the 20 S proteasome.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Increasing the potency of MHC class II-presented epitopes by linkage to Ii-Key peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

An algorithm for the prediction of proteasomal cleavages

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

1 reference

7 January 2021

Towards the rational design of Th1 adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Role of T-bet in commitment of TH1 cells before IL-12-dependent selection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

The specificity of proteasomes: impact on MHC class I processing and presentation of antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Design and evaluation of antigen-specific vaccination strategies against cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

The prime-boost strategy: exciting prospects for improved vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

The crystal structure of a T cell receptor in complex with peptide and MHC class II

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Transcriptional regulation of Th1/Th2 polarization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Thymic selection is influenced by subtle structural variation involving the p4 residue of an MHC class I-bound peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Immunological concepts of vaccine adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Vaccines against intracellular infections requiring cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Therapeutic vaccines against melanoma and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Specificity of the proteasome and the TAP transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

“Decisions, decisions ...”: β-catenin–mediated activation of TCF-1 and Lef-1 influences the fate of developing T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2802%2900131-1

7 January 2021

10.1016/S0168-1656(02)00131-1

Identifiers

DOI

1 reference

4 August 2017

1 reference